Peer-reviewed Articles
1. Trepanier A, Ahrens M, McKinnon W, Peters J, Stopfer J, Grumet S, Hunt K, et al. Genetic cancer risk assessment and counseling: Recommendation of the National Society of Genetic Counselor. Journal of Genetic Counseling. 2004; 3(2):83-114.
2. Brewer MA, Utzinger U, Barton JK, Hoying JB, Kirkpatrick ND, Brands WR, Davis JR, Hunt K, et al. Imagine of the ovary. Technology in Cancer Research and Treatment. 2004; 3(6):617-27.
3. Lindor NM, Lindor R, Apicella C, Dowty J, Ashley A, Hunt K, et al. Predicting BRCA1 and BRCA2 gene mutation carriers; comparison of LAMBA, BRCAPRO, myriad II and modified couch models. Familial Cancer. 2007; 6:473-482.
4. Lindor NM, Johnson KJ, Harvey H, Shane Pankratz V, Domchek SM, Hunt K, et al. Predicting BRCA1 and BRCA2 gene mutation carriers: comparison of PENN II model to previous study. Familial Cancer. 2010 Dec; 9(4):495-502.
5. Pipe T, Fisher C, Levey S, Hunt K, Wood A. Coping with breast cancer and long-term health promotion: examining maladaptive communication between mothers and young-adult daughters. Oncology Nursing Forum. 2011 March; 38(2):E125.
6. Raskin L, Schwenter F, Freytsis M, Tischkowitz M, Wong N, Chong G, Narod SA, Levine DA, Thibodeau SN, Hunt KS, et al. Characterization of two Ashkenazi Jewish founder mutations in MSH6 gene causing Lynch syndrome. Clin Genet. 2011 Jun; 79(6):512-22.
7. Files JA, Frey KA, David PS, Hunt KS, et al. Developing a Reproductive Live Plan. Journal of Midwifery & Women’s Health. 2011 Sep-Oct;56(5):468-74.
8. Bronson DR, Culver JO, Skrzynia C, Senter LA, Peters JA, Costalas JW, Callif-Daley F, Grumet SC, Hunt KS, et al. Essential elements of genetic cancer risk assessment, counseling and testing: Updated recommendations of the National Society of Genetic Counselors. Journal of Genetic Counseling. 2012 Apr; 21(2):151-161.
9. Roberts ME, Riegert-Johnson DL, Thomas BC, Thomas CS, Heckman MG, Krishna M, DiCaudo DJ, Bridges AG, Hunt KS, et al. Screening for muir-torre syndrome using mismatch repair protein immunohistochemistry of sebaceous neoplasms. Journal of Genetic Counseling. 2013 Jun;22(3):393-405.
10. Caselli R, Langbaum J, Marchant G, Lindor R, Hunt K, Robert J. An internet-based survey assessing public attitudes about preclinical testing for Alzheimer’s disease. Alzheimer’s and Dementia. 2013 Jul;9(4) SP545-P546.
11. Borad MJ, Champion MD, Egan JB, Liang WS, Fonseca R, Bryce AH, McCullough AE, Barrett MT, Hunt K, et al. Integrated genomic characterization reveals novel, therapeutically relevant drug targets in FGFR and EGFR pathways in sporadic intrahepatic cholangiocarcinomas. PLoS Genetics. 2014 Feb;http://dx.doi.org/10.1371/journal.pgen.1004135.
12. Caselli RJ, Langbaum JB, Marchant GE, Lindor RA, Hunt KS, et al. Predictive testing for Alzheimer’s disease: suicidal ideation in healthy participants. Alzheimer’s and Dementia. 2014 Jul;10(4)SP610.
13. Caselli RJ, Langbaum J, Marchant GE, Lindor RA, Hunt KS, et al. Public perceptions of presymptomatic testing for Alzheimer’s disease. Mayo Clinic Proceedings. 2014 Oct;89(10):1389-96.
